GL1X · GenesisL1 explorer

Research workbench

HIV-1 pr mutant in complex with nelfinavir

Analyse HIV-1 pr mutant in complex with nelfinavir in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2QAK
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease retropepsin
EC
3.4.23.16
UniProt
P03367
Ligands
1UN
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BProtease retropepsin (EC 3.4.23.16)protein997% helix, 55% strandP03367

Ligands and binding sites

  • 1UN · 2-[2-hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenyl sulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13720.720.84331UN

Interfaces

1 interface between chains.

  • A–B · 1821 Ų buried · 40 hydrogen bonds · protein-protein

Compared structures

  • 2QAK · HIV-1 PR mutant in complex with nelfinavir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.